In agreement with this, Gomaraschi et al. report that low LAL activity in liver biopsies of NAFLD patients was shown to be independent of LAL expression (Gomaraschi et al., 2019). The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatotic liver disease.